NCT01983514View on ClinicalTrials.gov

Effects of Intranasal Administration of a Single Dose of Oxytocin Using a Novel Device in Healthy Adults

PHASE1CompletedINTERVENTIONAL
Enrollment

19

Participants

Timeline

Start Date

October 31, 2013

Primary Completion Date

February 28, 2014

Study Completion Date

February 28, 2014

Conditions
Healthy Male Adults
Interventions
DRUG

8IU intranasal oxytocin

DRUG

24 IU intranasal oxytocin

DRUG

1 IU intravenous oxytocin

DRUG

Placebo

Trial Locations (1)

Unknown

Norwegian Centre for Mental Disorders Research (NORMENT), KG Jebsen Centre for Psychosis Research - TOP Study, Oslo

Sponsors

Lead Sponsor

OptiNose AS
All Listed Sponsors
collaborator

University of Oslo

OTHER

lead

OptiNose AS

INDUSTRY